Well, best of luck mate.
Will say that valuation was before the legal cost threat though.
POH needs a bit of time so maybe SIAC will do its normal thing and take forever to hand down its decision.
Where is the main part of POH's business these days? Animal or human? Could POH (just an example) try and sell off its animal business and concentrate purely on the Human business? That could give it a way chest and allow funds to fast track research.
That would limit its options as well.
- Forums
- ASX - By Stock
- Ann: Receipt of R&D Tax Incentive
Well, best of luck mate. Will say that valuation was before the...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
POH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online